Analysts See $0.27 EPS for Brookline Bancorp, Inc. (BRKL); THERALASE TECHNOLOGIES ORDINARY SHAR (TLTFF) Sellers Decreased By 22.86% Their Shorts

Theralase Technologies Inc. (OTCMKTS:TLTFF) Logo

THERALASE TECHNOLOGIES INC ORDINARY SHAR (OTCMKTS:TLTFF) had a decrease of 22.86% in short interest. TLTFF’s SI was 181,200 shares in January as released by FINRA. Its down 22.86% from 234,900 shares previously. With 89,500 avg volume, 2 days are for THERALASE TECHNOLOGIES INC ORDINARY SHAR (OTCMKTS:TLTFF)’s short sellers to cover TLTFF’s short positions. The stock increased 0.85% or $0.0021 during the last trading session, reaching $0.25. About shares traded. Theralase Technologies Inc. (OTCMKTS:TLTFF) has 0.00% since January 11, 2018 and is . It has by 0.00% the S&P500.

Analysts expect Brookline Bancorp, Inc. (NASDAQ:BRKL) to report $0.27 EPS on January, 30.They anticipate $0.06 EPS change or 28.57% from last quarter’s $0.21 EPS. BRKL’s profit would be $21.71M giving it 13.04 P/E if the $0.27 EPS is correct. After having $0.28 EPS previously, Brookline Bancorp, Inc.’s analysts see -3.57% EPS growth. The stock decreased 0.14% or $0.02 during the last trading session, reaching $14.08. About 239,724 shares traded. Brookline Bancorp, Inc. (NASDAQ:BRKL) has declined 8.66% since January 11, 2018 and is downtrending. It has underperformed by 8.66% the S&P500. Some Historical BRKL News: 26/04/2018 – BROOKLINE BANCORP INC BRKL.O : COMPASS POINT RAISES TARGET PRICE TO $21 FROM $20; 09/04/2018 – CBS-TV 3: Armed barricaded subject on Brookline Ave. in Agawam; 25/04/2018 – BROOKLINE BANCORP 1Q EPS 24C, EST. 25C; 25/04/2018 – Brookline Bancorp Raises Dividend to 10c; 25/04/2018 – BROOKLINE BANCORP BOOSTS QTRLY DIV 11.1%; 25/04/2018 – BROOKLINE BANCORP BOOSTS QTR DIV/SHR TO 10C FROM 9C, EST. 9C; 08/03/2018 Brookline Bank Introduces New Suite of Foreign Exchange Services; 20/04/2018 – DJ Brookline Bancorp Inc, Inst Holders, 1Q 2018 (BRKL); 25/04/2018 – Brookline Bancorp 1Q EPS 24c

Theralase Technologies Inc. designs, develops, makes, and markets super-pulsed cold laser technology for a range of human, companion animal, and equine applications. The company has market cap of $33.44 million. The firm operates in two divisions, Therapeutic Laser Technology and Photo Dynamic Therapy. It currently has negative earnings. It engages in the production, marketing, and distribution of TLC-1000 and TLC-2000 laser technology for the treatment of nerve, muscle, tendon, ligament, joint, and wound conditions through the elimination of pain, reduction of inflammation, and acceleration of tissue healing.

Investors sentiment decreased to 1.17 in 2018 Q3. Its down 0.02, from 1.19 in 2018Q2. It dived, as 7 investors sold Brookline Bancorp, Inc. shares while 46 reduced holdings. 11 funds opened positions while 51 raised stakes. 61.08 million shares or 2.38% more from 59.66 million shares in 2018Q2 were reported. Everence Management Inc has invested 0.04% of its portfolio in Brookline Bancorp, Inc. (NASDAQ:BRKL). Banc Funds Com Limited Liability Company reported 197,800 shares. Gemmer Asset Management Limited Liability holds 184 shares or 0% of its portfolio. Massachusetts Ser Communications Ma has invested 0.01% in Brookline Bancorp, Inc. (NASDAQ:BRKL). Ny State Common Retirement Fund stated it has 0% in Brookline Bancorp, Inc. (NASDAQ:BRKL). Baystate Wealth Llc holds 0.03% or 10,670 shares in its portfolio. Mason Street Advsrs Llc holds 23,828 shares. Winslow Evans Crocker holds 1,094 shares. Charter invested in 0.09% or 46,032 shares. First Manhattan accumulated 293,104 shares or 0.03% of the stock. Goldman Sachs has 2.41M shares for 0.01% of their portfolio. Thrivent For Lutherans holds 56,208 shares. Profund Advisors Ltd Liability Corp accumulated 13,927 shares or 0.01% of the stock. Clarivest Asset Ltd Liability Com reported 0% of its portfolio in Brookline Bancorp, Inc. (NASDAQ:BRKL). Eagle Asset Management Inc invested 0.04% in Brookline Bancorp, Inc. (NASDAQ:BRKL).

Brookline Bancorp, Inc. operates as the holding firm for Brookline Bank, Bank Rhode Island, First Ipswich Bank, and Brookline Securities Corp that provide commercial, business, and retail banking services to corporate, municipal, and retail customers. The company has market cap of $1.13 billion. It accepts various deposit products, including demand checking, NOW, savings, money market, and certificate of deposit accounts. It has a 16.13 P/E ratio. The firm also offers loans, such as first mortgage loans secured by commercial, multi-family, and residential real estate properties; loans to business entities comprising commercial lines of credit; loans to condominium associations; and loans and leases used to finance equipment used by small businesses.

More notable recent Brookline Bancorp, Inc. (NASDAQ:BRKL) news were published by: Nasdaq.com which released: “These 5 Stocks Make Great Buys on New Analyst Coverage – Nasdaq” on January 08, 2019, also Nasdaq.com with their article: “Zacks.com featured expert Kevin Matras highlights: Net Lease, K12, Brookline Bancorp, Catalyst Biosciences and Knoll – Nasdaq” published on January 09, 2019, Globenewswire.com published: “Brookline Bancorp, Inc. Announces Approval of Stock Repurchase Program – GlobeNewswire” on December 06, 2018. More interesting news about Brookline Bancorp, Inc. (NASDAQ:BRKL) were released by: Globenewswire.com and their article: “Brookline Bancorp, Inc. Names Joanne Chang to Board of Directors – GlobeNewswire” published on September 26, 2018 as well as Nasdaq.com‘s news article titled: “Brookline Bancorp, Inc. Announces Fourth Quarter 2018 Earnings Release Date and Conference Call – Nasdaq” with publication date: January 07, 2019.

Brookline Bancorp, Inc. (NASDAQ:BRKL) Institutional Positions Chart